1. The successful implementator; of intensification and chaining for sIPV production fed to a drastically reduced equipment size enabling the process to be operated within a closed system, in a low footprint isolator, called micro-facility system, NevoLine. 2. Thanks to imoroved recoveries, the intensified process achieves high productivity. delivering 525,000 doses of trrvatent sIPV per batch, 3. With Univercells NevoLine technology, viral vaccines such as polio can be produced in a miniaturized fully-contained isolator for increased safety, leading to a tremendous impact on the factory design. CAPEX and cost of manufacturing.
展开▼
